SACHDEV AMIT (EVP, CRO) sold 49.9% of their position (58.61K shares) of VERTEX PHARMACEUTICALS INC / MA on the open market
Open‑market sale worth $27.48M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+23.48K
Price / share
$155.57
Trade value
$3.65M
% of position
Common Stock
Shares
+25.03K
Price / share
$187.53
Trade value
$4.69M
% of position
Common Stock
Shares
−920.00
Price / share
$463.91
Trade value
$426.80K
% of position
Common Stock
Shares
−2.73K
Price / share
$465.05
Trade value
$1.27M
% of position
Common Stock
Shares
−1.85K
Price / share
$465.80
Trade value
$860.80K
% of position
Common Stock
Shares
−10.26K
Price / share
$467.75
Trade value
$4.80M
% of position
Common Stock
Shares
−19.66K
Price / share
$468.57
Trade value
$9.21M
% of position
Common Stock
Shares
−7.24K
Price / share
$469.61
Trade value
$3.40M
% of position
Common Stock
Shares
−11.71K
Price / share
$470.54
Trade value
$5.51M
% of position
Common Stock
Shares
−4.24K
Price / share
$471.43
Trade value
$2M
% of position
Net shares
−10.11K
Net value
-$19.13M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/19/2026 | M · Option Exercise | +23.48K | $155.57 | $3.65M | 34.0% | 69.04K | 92.52K |
| Common Stock Direct | 2/19/2026 | M · Option Exercise | +25.03K | $187.53 | $4.69M | 27.0% | 92.52K | 117.55K |
| Common Stock Direct | 2/19/2026 | S · Sale | −920.00 | $463.91 | $426.80K | 0.8% | 117.55K | 116.63K |
| Common Stock Direct | 2/19/2026 | S · Sale | −2.73K | $465.05 | $1.27M | 2.3% | 116.63K | 113.90K |
| Common Stock Direct | 2/19/2026 | S · Sale | −1.85K | $465.80 | $860.80K | 1.6% | 113.90K | 112.05K |
| Common Stock Direct | 2/19/2026 | S · Sale | −10.26K | $467.75 | $4.80M | 9.2% | 112.05K | 101.79K |
| Common Stock Direct | 2/19/2026 | S · Sale | −19.66K | $468.57 | $9.21M | 19.3% | 101.79K | 82.12K |
| Common Stock Direct | 2/19/2026 | S · Sale | −7.24K | $469.61 | $3.40M | 8.8% | 82.12K | 74.88K |
| Common Stock Direct | 2/19/2026 | S · Sale | −11.71K | $470.54 | $5.51M | 15.6% | 74.88K | 63.17K |
| Common Stock Direct | 2/19/2026 | S · Sale | −4.24K | $471.43 | $2M | 6.7% | 63.17K | 58.93K |
| Total | −10.11K | -$19.13M | ||||||
Stock Option (Right to Buy)
Common Stock
23.48K shares
Shares
−23.48K
Strike price
155.57
Held after
0.00
Exercisable
—
Stock Option (Right to Buy)
Common Stock
25.03K shares
Shares
−25.03K
Strike price
187.53
Held after
0.00
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock23.48K shares | 2/19/2026 | M · Option Exercise | −23.48K | 155.57 | — | 0.00 |
| Stock Option (Right to Buy) Direct | Common Stock25.03K shares | 2/19/2026 | M · Option Exercise | −25.03K | 187.53 | — | 0.00 |
Common Stock
IndirectCommon Stock
Indirect| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 9.30K | Indirect |
| Common Stock | 882.00 | Indirect |
| Total | 10.18K | 10.18K indirect |